Thelansis

Schizophrenia Epidemiology Insights Thelansis’s “Schizophrenia Epidemiology Insights and Forecast Report – 2020 To 2040″ provides an analysis of disease burden, characterized by disease definition, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies. Key business questions answered: 20-year historical and forecast data (2020–2040) Disease definition based on globally accepted and latest criteria (e.g., ICD-10 codes) Granular patient population coverage by year and geography Detailed segmentation by age, gender, subpopulations, comorbidities, line of therapies, etc. Patient fu...

Schizophrenia Epidemiology Insights Thelansis’s “Schizophrenia Epidemiology Insights and Forecast Report – 2020 To 2040″ provides an analysis of disease burden, characterized by disease definition, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies. Schizophrenia Overview Schizophrenia, a persistent and debilitating brain disorder, is typically characterized by two sets of symptoms: positive and negative. Those with schizophrenia often experience symptoms that leave them feeling fearful and withdrawn, with their speech and behavior becoming so disorganized that they can be incomprehensible or alarming to...